Associations between neurodegenerative and acute injury biomarkers and post‐stroke cognitive impairment – the Nor‐COAST study
Zusammenhänge zwischen neurodegenerativen und akuten Verletzungs-Biomarkern und kognitiver Beeinträchtigung nach Schlaganfall – die Nor-COAST-Studie
Alzheimer's & Dementia · 2025-12 · 21 (S2)
DOI: 10.1002/alz70856_101515 ↗Auf einen Blick
Bei 547 Schlaganfallpatient:innen waren höhere akute BD-tau-, NfL- und p-tau181-Spiegel mit schlechteren MoCA-Werten bis 36 Monate assoziiert. Die Zusammenhänge nahmen nach Berücksichtigung klinischer Parameter ab.
Fragestellung
Ob hohe Plasmawerte neurodegenerativer und akuter Verletzungs-Biomarker zu Beginn nach Schlaganfall eine post-stroke cognitive impairment (PSCI) vorhersagen.
Methode
Nor-COAST-Substudie mit 547 Schlaganfallpatient:innen; Messung von BD-tau, p-tau181, t-tau, Aβ40, Aβ42, GFAP und NfL im Plasma bei Einschluss sowie nach 3, 18 und 36 Monaten; Analyse mit MoCA bis 36 Monate.
Ergebnisse
In den ersten 3 Monaten sanken BD-tau um 43 %, t-tau um 20 % und GFAP um 76 %; NfL nahm bis 18 Monate um 59 % ab, p-tau181 stieg bis 36 Monate um 24 %. Höhere akute BD-tau-, NfL- und p-tau181-Werte sagten niedrigere MoCA-Werte bei ischämischem Schlaganfall voraus (p < 0,05).
Schlussfolgerung der Autor:innen
Die Autoren schließen, dass Schlaganfall einen fortlaufenden neurodegenerativen Prozess auslöst; steigendes p-tau181 sei mit PSCI verbunden.
Kernaussagen
- 547 Schlaganfallpatient:innen wurden longitudinal untersucht
- Höhere akute BD-tau-, NfL- und p-tau181-Werte sagten schlechtere MoCA-Werte voraus
- Der Zusammenhang fand sich nur bei ischämischem Schlaganfall
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 24.12.2025. Verfasst von Anne‐Brita Knapskog und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Patients with vascular risk factors have a higher incidence of Alzheimer's disease (AD), and AD patients have an increased risk of experiencing stroke. About half of all stroke survivors experience post‐stroke cognitive impairment (PSCI). Stroke triggers numerous inflammatory and neurodegenerative processes both in the acute and chronic phases. The aims of this study were to investigate longitudinal plasma biomarker data in a stroke population and whether high levels of neurodegenerative and acute injury biomarkers at baseline could predict PSCI.
Method
In this Nor‐COAST substudy, we included 547 stroke patients (Age [mean = 73± 12], 56 % males, 89 % ischemic strokes, 11 % haemorrhagic strokes). Brain‐derived tau (BD‐tau), phosphorylated tau 181 ( p ‐tau 181 ), total tau (t‐tau), amyloid β40 (Aβ 40 ), Aβ 42 , glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) concentrations were measured on the Simoa platform in plasma samples collected at inclusion, and after 3, 18 and 36 months. We explored the biomarkers’ associations with cognitive decline as measured by the Montreal Cognitive Assessment (MoCA) scale up to 36 months post‐stroke.
Result
Within the first three months BD‐tau, t‐tau, and GFAP concentrations declined by 43%, 20% and 76% respectively, whereas NfL levels continued to decrease up to 18 months (59%). p ‐tau 181 increased gradually by 24 % from acute phase to 36 months. Aβ 42 remained unchanged. Higher acute phase concentrations of BD‐tau, NfL and p ‐tau 181 predicted lover MoCA score up to 36 months post‐stroke in patients with ischemic stroke ( p value < 0.05). However, including clinical parameters attenuated the associations. These associations were not found in the patients with haemorrhagic stroke.
Conclusion
Concentrations of plasma BD‐tau, NfL, GFAP, and t‐tau were increased in the acute phase of stroke, but no significant change was seen for Aβ 42 . BD‐tau, t‐tau and GFAP concentrations decreased to stable levels within 3 months of event, NfL stabilized within 18 months, whereas p ‐tau181 showed an increase. Higher concentrations of BD‐tau, NfL, and p ‐tau 181 were associated with worse cognitive outcome up to 36 months post‐stroke. These results indicate that stroke trigger a continuing neurodegenerative process, as demonstrated by gradually increasing concentrations of p ‐tau 181 leading to PSCI.
Zitieren
APA
Knapskog, A., Molfetta, G. D., Sandvig, H. V., Blennow, K., Zetterberg, H., Aam, S. V., Saltvedt, I. V., & Ashton, N. (2025). Associations between neurodegenerative and acute injury biomarkers and post‐stroke cognitive impairment – the Nor‐COAST study. Alzheimer's & Dementia, 21(S2). https://doi.org/10.1002/alz70856_101515
Vancouver
Knapskog A, Molfetta GD, Sandvig HV, Blennow K, Zetterberg H, Aam SV, et al. Associations between neurodegenerative and acute injury biomarkers and post‐stroke cognitive impairment – the Nor‐COAST study. Alzheimer's & Dementia. 2025;21(S2). doi:10.1002/alz70856_101515
BibTeX
@article{Knapskog2025,
author = {Knapskog, Anne‐Brita and Molfetta, Guglielmo Di and Sandvig, Heidi Vihovde and Blennow, Kaj and Zetterberg, Henrik and Aam, Stina Vihovde and Saltvedt, Ingvild Vihovde and Ashton, Nicholas},
title = {Associations between neurodegenerative and acute injury biomarkers and post‐stroke cognitive impairment – the Nor‐COAST study},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {S2},
doi = {10.1002/alz70856_101515}
}
EUVIMED